doi: 10.1016/0731-7085(93)80100-f.
Chiral drugs: the FDA perspective on manufacturing and control
Affiliations
- PMID: 8123731
- DOI: 10.1016/0731-7085(93)80100-f
Item in Clipboard
Chiral drugs: the FDA perspective on manufacturing and control
J Pharm Biomed Anal.
1993 Nov-Dec.
Abstract
On 27 May 1992, the FDA announced the availability of a policy statement on the development of stereoisomeric drugs. This statement has significant implications for the chemist who is working on the development and validation of analytical controls for chiral drug substances and products. The testing of the bulk drug, the manufacturing of the finished product, the design of stability testing protocols, and the labelling of the drug must all take the chirality of the active ingredient into consideration.
Similar articles
-
FDA perspective on specifications for biotechnology products--from IND to PLA.Dev Biol Stand. 1997;91:3-13. Dev Biol Stand. 1997. PMID: 9413677 Review.
-
Pharmaceutical product integrity: can the FDA assure quality?Manag Care. 2004 Mar;13(3 Suppl):30-3. Manag Care. 2004. PMID: 15074168 No abstract available.
-
FDA tightens its grip on drug regulation.BMJ. 2007 Feb 10;334(7588):290-1. doi: 10.1136/bmj.39119.546181.59. BMJ. 2007. PMID: 17289729 Free PMC article.
-
FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs.Food Drug Law J. 1999;54(3):463-87. Food Drug Law J. 1999. PMID: 11797710 No abstract available.
-
Chiral drugs: an industrial analytical perspective.J Pharm Biomed Anal. 1991;9(5):363-82. doi: 10.1016/0731-7085(91)80160-b. J Pharm Biomed Anal. 1991. PMID: 1932271 Review.
Cited by
-
Enantiospecific analysis: applications in bioanalysis and metabolism.Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):241-51. doi: 10.1007/BF03188927. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867667 Review.
-
Chromatographic Determination of the Absolute Configuration in Sanjoinine A That Increases Nitric Oxide Production.Biomol Ther (Seoul). 2023 Sep 1;31(5):566-572. doi: 10.4062/biomolther.2023.028. Epub 2023 Apr 6. Biomol Ther (Seoul). 2023. PMID: 37019875 Free PMC article.
-
The Use of Dual Cyclodextrin Chiral Selector Systems in the Enantioseparation of Pharmaceuticals by Capillary Electrophoresis: An Overview.Molecules. 2021 Apr 14;26(8):2261. doi: 10.3390/molecules26082261. Molecules. 2021. PMID: 33919692 Free PMC article. Review.
-
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy.Pharmaceuticals (Basel). 2022 Feb 17;15(2):240. doi: 10.3390/ph15020240. Pharmaceuticals (Basel). 2022. PMID: 35215352 Free PMC article. Review.
-
Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase.Molecules. 2023 Sep 8;28(18):6518. doi: 10.3390/molecules28186518. Molecules. 2023. PMID: 37764294 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
